Vir Biotechnology, Inc. (VIR)

Vir Biotechnology Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	20.86	74.21	86.18	1,616	1,095	76.37
Revenue Growth (YoY)	-73.79%	-13.89%	-94.67%	47.50%	1334.39%	843.86%
Cost of Revenue	497.73	478.65	572.83	620.97	513.87	301.58
Gross Profit	-476.87	-404.44	-486.65	994.83	581.54	-225.21
Selling, General & Admin	106.65	119.03	174.44	161.76	160.79	70.94
Operating Expenses	106.65	119.03	174.44	161.76	160.79	70.94
Operating Income	-583.52	-523.47	-661.09	833.07	420.75	-296.15
Interest & Investment Income	62.81	71.81	86.99	28.09	0.44	2.84
Other Non Operating Income (Expenses)	-2.01	-2.22	-8.99	4.26	-9.44	-4.47
EBT Excluding Unusual Items	-522.71	-453.88	-583.09	865.42	411.75	-297.78
Merger & Restructuring Charges	-35.03	-35	-13.56	-	-	-
Gain (Loss) on Sale of Investments	6.77	-5.53	-21.89	-111.14	138.05	-
Asset Writedown	-14.55	-14.55	-9.66	-	-	-0.83
Other Unusual Items	-13.53	-14.15	-	-	-	-
Pretax Income	-579.05	-523.11	-628.19	754.28	549.8	-298.61
Income Tax Expense	-1.41	-1.15	-13.08	238.44	21.22	0.05
Earnings From Continuing Operations	-577.65	-521.96	-615.12	515.84	528.58	-298.67
Minority Interest in Earnings	-	-	0.06	-	-	-
Net Income	-577.65	-521.96	-615.06	515.84	528.58	-298.67
Net Income to Common	-577.65	-521.96	-615.06	515.84	528.58	-298.67
Net Income Growth	-	-	-	-2.41%	-	-
Shares Outstanding (Basic)	137	136	134	133	130	119
Shares Outstanding (Diluted)	137	136	134	135	133	119
Shares Change (YoY)	1.66%	1.58%	-0.50%	1.03%	11.98%	292.62%
EPS (Basic)	-4.22	-3.83	-4.59	3.89	4.07	-2.51
EPS (Diluted)	-4.22	-3.83	-4.59	3.83	3.96	-2.51
EPS Growth	-	-	-	-3.28%	-	-
Free Cash Flow	-422.14	-453.65	-800.36	1,595	-69.41	-197.49
Free Cash Flow Per Share	-3.09	-3.33	-5.97	11.83	-0.52	-1.66
Gross Margin	-	-	-	61.57%	53.09%	-294.90%
Operating Margin	-2797.18%	-705.44%	-767.10%	51.56%	38.41%	-387.79%
Profit Margin	-2769.04%	-703.40%	-713.69%	31.92%	48.25%	-391.09%
Free Cash Flow Margin	-2023.57%	-611.35%	-928.71%	98.73%	-6.34%	-258.60%
EBITDA	-570.61	-508.91	-641.64	839.85	426.56	-290.71
EBITDA Margin	-	-	-	51.98%	38.94%	-
D&A For EBITDA	12.91	14.56	19.45	6.78	5.81	5.44
EBIT	-583.52	-523.47	-661.09	833.07	420.75	-296.15
EBIT Margin	-	-	-	51.56%	38.41%	-
Effective Tax Rate	-	-	-	31.61%	3.86%	-
Revenue as Reported	20.86	74.21	86.18	1,616	1,095	76.37

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q